+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Point-Of-Care Or Rapid Diagnostics Market - Global Forecast 2026-2032- Product Image
Point-Of-Care Or Rapid Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

Point-Of-Care Or Rapid Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127003
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Point-Of-Care Or Rapid Diagnostics Market is projected to reach USD 52.62 Billion in 2026. It is expected to continue growing at a CAGR of 8.45%, reaching USD 85.79 Billion by 2032.

Point-of-Care Diagnostics: Executive Overview

Point-of-care and rapid diagnostics bring testing closer to patients, enabling results in clinics, pharmacies, emergency settings, workplaces, homes, and field environments. Their strategic value rests on shorter decision cycles, reduced dependence on centralized laboratories, and improved access where transport, staffing, or infrastructure constraints delay conventional testing. Adoption is shaped by analytical performance, ease of use, reimbursement, regulatory requirements, connectivity, and the ability to integrate results into clinical workflows.

Decentralization and Workflow Integration Are Reshaping Testing

The landscape is shifting from laboratory-centered testing toward distributed models that combine rapid assays, portable instruments, connected devices, and decentralized care pathways. Multiplexing, improved sample preparation, noninvasive or minimally invasive sampling, and digital result transmission are expanding the range of use cases. At the same time, regulators and healthcare providers are placing greater emphasis on quality management, operator training, usability, confirmatory testing, and equitable access. Successful deployment increasingly depends on embedding diagnostics into established referral, treatment, and reporting systems rather than treating tests as standalone products.

Artificial Intelligence Strengthens Interpretation, Triage, and Quality Control

Artificial intelligence is contributing to point-of-care diagnostics through image interpretation, signal processing, risk stratification, workflow prioritization, and quality-control monitoring. Its cumulative effect is strongest when algorithms support, rather than replace, validated diagnostic pathways. AI can help identify abnormal results, reduce interpretation variability, guide repeat testing, and connect findings with clinical decision support. However, dependable use requires representative training data, transparent validation, cybersecurity, human oversight, clear liability arrangements, and safeguards against performance degradation across populations, devices, and care settings.

Regional Conditions Determine Adoption Pathways

North America is characterized by strong clinical infrastructure, high digital connectivity, and close attention to regulatory evidence, reimbursement, and interoperability. Latin America is prioritizing access, decentralized services, and public-health applications while managing uneven laboratory capacity and procurement conditions. Europe is emphasizing regulatory compliance, data governance, cross-border interoperability, and integration with primary care. The Middle East is combining investment in advanced healthcare infrastructure with demand for rapid screening and decentralized services. Africa is applying point-of-care testing to infectious diseases, maternal care, and remote access challenges, with affordability, supply continuity, and workforce training remaining central. Asia-Pacific spans highly advanced health systems and rapidly expanding decentralized care, creating demand for scalable, mobile, and digitally connected testing models.

Economic and Alliance Groups Reveal Distinct Priorities

ASEAN economies are emphasizing accessible testing, regional disease surveillance, and solutions adaptable to varied healthcare infrastructure. BRICS members reflect diverse priorities, including domestic manufacturing, public-health resilience, affordability, and reduced dependence on external supply chains. The European Union is focused on harmonized regulation, data protection, interoperability, and consistent quality across member states. G7 health systems are prioritizing preparedness, innovation, evidence generation, and integration with sophisticated clinical networks. GCC countries are advancing centralized digital health strategies alongside rapid testing for hospitals, travel, occupational health, and community services. NATO members are also attentive to operational readiness, deployable medical capabilities, biosurveillance, and resilient supply arrangements.

Country-Level Priorities Reflect Diverse Health-System Needs

Australia is suited to decentralized testing across remote communities and integrated primary care. Brazil is balancing broad geographic access with public-health surveillance and domestic production goals. Canada is addressing rural and Indigenous-community access while maintaining rigorous evidence and quality expectations. China is combining large-scale healthcare delivery with manufacturing capacity and digital integration. France, Germany, Italy, and Spain are aligning adoption with European regulatory and reimbursement frameworks while strengthening outpatient and hospital workflows. India is emphasizing affordability, primary-care reach, infectious-disease control, and scalable manufacturing. Japan and South Korea are combining advanced healthcare infrastructure with automation, aging-population needs, and digital connectivity. Mexico is focused on access, public-health programs, and service delivery across uneven infrastructure. Russia faces requirements related to geographic reach, supply resilience, and domestic capability. The United Kingdom is evaluating rapid diagnostics through evidence-based commissioning, decentralized care, and national health-system interoperability. The United States is emphasizing regulatory validation, reimbursement, emergency preparedness, home testing, and integration with clinical data systems.

Prioritize Evidence, Interoperability, and Deployment Readiness

Industry leaders should design products around specific clinical decisions and measurable workflow benefits rather than speed alone. They should generate evidence across intended users, settings, and demographic groups; build quality controls and confirmatory pathways into deployment plans; and pursue interoperability with electronic health records and public-health reporting systems. Commercial and public-sector strategies should account for procurement cycles, reimbursement, training, consumables availability, maintenance, and waste management. Partnerships with healthcare providers, laboratories, regulators, and community organizations can improve adoption. AI-enabled offerings should include governance, monitoring, explainability, cybersecurity, and clear escalation procedures from the outset.

Methodology for a Reliable Executive Assessment

This executive assessment uses a structured qualitative synthesis of the point-of-care and rapid diagnostics landscape. It evaluates technology trends, care-delivery models, regulatory and reimbursement considerations, regional infrastructure, country-level health-system priorities, and the implications of artificial intelligence. Insights are organized across the required regions, economic and alliance groups, and countries, with emphasis on recurring adoption drivers, implementation barriers, and operational requirements. The assessment intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific claims, and interprets the supplied market reference solely as a scope definition.

Execution Quality Will Determine the Next Phase of Adoption

Point-of-care and rapid diagnostics are becoming important components of distributed, digitally connected healthcare. Their impact will depend less on turnaround time in isolation than on accuracy, usability, affordability, workflow fit, data integration, and continuity of supply. Regional and country differences require adaptable deployment models, while AI creates additional value only when supported by rigorous validation and governance. Leaders that combine strong evidence with practical implementation capabilities will be best positioned to expand access and improve timely clinical decision-making.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Point-Of-Care Or Rapid Diagnostics Market, by Product Offering
7.1. Introduction
7.2. Instruments
7.2.1. Handheld
7.2.2. Benchtop
7.3. Consumables
7.3.1. Test Cartridges & Cassettes
7.3.2. Test Strips
7.3.3. Reagent Kits & Panels
7.3.4. Collection Devices
7.4. Software & Services
7.4.1. Device & Test Management Software
7.4.2. Maintenance, Training & Support
8. Point-Of-Care Or Rapid Diagnostics Market, by Technology
8.1. Introduction
8.2. Immunoassay
8.3. Molecular Diagnostics
8.4. Microfluidics & Lab-On-Chip
8.5. Biosensor-Based
8.6. Clinical Chemistry
9. Point-Of-Care Or Rapid Diagnostics Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Urine
9.4. Respiratory Specimens
9.5. Saliva & Oral Specimens
9.6. Stool
10. Point-Of-Care Or Rapid Diagnostics Market, by Mode of Purchase
10.1. Introduction
10.2. Over-the-Counter
10.3. Prescription-Based Diagnostics
11. Point-Of-Care Or Rapid Diagnostics Market, by Application
11.1. Introduction
11.2. Infectious Disease Testing
11.2.1. Respiratory Infections
11.2.2. Sexually Transmitted Infections
11.2.3. Gastrointestinal Infections
11.2.4. Tropical & Vector-Borne
11.3. Cardiometabolic Testing
11.4. Hematology & Coagulation Testing
11.4.1. Coagulation Monitoring
11.4.2. Hematology Screening
11.4.3. Inflammation & Infection Support
11.5. Pregnancy, Fertility & Women’s Health
11.6. Oncology & Immunology Testing
11.6.1. Oncology Biomarkers
11.6.2. Immunology & Autoimmune
11.6.3. Endocrine & Immune Adjunct
11.7. Toxicology & Substance Use Testing
11.8. Critical Care & Emergency Testing
12. Point-Of-Care Or Rapid Diagnostics Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Care
12.4. Hospitals
12.5. Mobile Testing
12.6. Physician Offices
13. Point-Of-Care Or Rapid Diagnostics Market, by Distribution Channels
13.1. Introduction
13.2. Direct Institutional Sales
13.3. Distributors & Wholesalers
13.4. Retail Pharmacy
13.5. E-commerce & Online
13.6. Government / Public Sector
14. Point-Of-Care Or Rapid Diagnostics Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Europe
14.5. Latin America
14.6. Africa
14.7. Middle East
15. Point-Of-Care Or Rapid Diagnostics Market, by Group
15.1. Introduction
15.2. NATO
15.3. G7
15.4. BRICS
15.5. European Union
15.6. ASEAN
15.7. GCC
16. Point-Of-Care Or Rapid Diagnostics Market, by Country
16.1. Introduction
16.2. United States
16.3. China
16.4. Canada
16.5. Germany
16.6. Japan
16.7. India
16.8. Brazil
16.9. Mexico
16.10. United Kingdom
16.11. France
16.12. Australia
16.13. Italy
16.14. South Korea
16.15. Russia
16.16. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Danaher Corporation
18.2. Abbott Laboratories
18.3. F. Hoffmann-La Roche Ltd.
18.4. bioMérieux SA
18.5. Becton, Dickinson and Company
18.6. QuidelOrtho Corporation
18.7. Werfen, S.A.
18.8. Bio-Rad Laboratories, Inc.
18.9. Siemens Healthineers AG
18.10. Biosynex SA
18.11. Cardinal Health, Inc.
18.12. Nova Biomedical Corporation
18.13. QIAGEN N.V.
18.14. Thermo Fisher Scientific Inc.
18.15. Illumina, Inc.
18.16. Abaxis, Inc.
18.17. Abionic SA
18.18. Biosurfit SA
18.19. Chembio Diagnostic Systems, Inc.
18.20. EKF Diagnostics Holdings plc
18.21. Helena Laboratories Corporation
18.22. Horiba Group
18.23. Microlife Corporation
18.24. Monlab SA
18.25. Quest Diagnostics Incorporated
18.26. Sekisui Diagnostics LLC
18.27. Sysmex Corporation
18.28. Trinity Biotech plc
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Point-Of-Care Or Rapid Diagnostics Market, Years Considered for the Study
FIGURE 2. Global Point-Of-Care Or Rapid Diagnostics Market, Research Design
FIGURE 3. Global Point-Of-Care Or Rapid Diagnostics Market, Research Framework
FIGURE 4. Global Point-Of-Care Or Rapid Diagnostics Market, Data Triangulation
FIGURE 5. Global Point-Of-Care Or Rapid Diagnostics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2025 vs 2032 (%)
FIGURE 7. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2025 vs 2032 (%)
FIGURE 13. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2025 vs 2032 (%)
FIGURE 19. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Point-Of-Care Or Rapid Diagnostics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Point-Of-Care Or Rapid Diagnostics Market Segmentation & Coverage
TABLE 2. Global Point-Of-Care Or Rapid Diagnostics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Handheld Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Handheld Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Handheld Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Benchtop Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Benchtop Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Benchtop Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Test Cartridges & Cassettes Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Test Cartridges & Cassettes Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Test Cartridges & Cassettes Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Test Strips Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Test Strips Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Test Strips Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Reagent Kits & Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Reagent Kits & Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Reagent Kits & Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Collection Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Collection Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Collection Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Device & Test Management Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Device & Test Management Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Device & Test Management Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Maintenance, Training & Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Maintenance, Training & Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Maintenance, Training & Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 38. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Microfluidics & Lab-On-Chip Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Microfluidics & Lab-On-Chip Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Microfluidics & Lab-On-Chip Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Biosensor-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Biosensor-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Biosensor-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Clinical Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Clinical Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Clinical Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 54. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Respiratory Specimens Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Respiratory Specimens Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Respiratory Specimens Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Saliva & Oral Specimens Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Saliva & Oral Specimens Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Saliva & Oral Specimens Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Stool Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Stool Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Stool Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 70. Global Over-the-Counter Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Over-the-Counter Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Over-the-Counter Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Prescription-Based Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Prescription-Based Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Prescription-Based Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Global Infectious Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Infectious Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Infectious Disease Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Respiratory Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Respiratory Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Respiratory Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Sexually Transmitted Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Sexually Transmitted Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Sexually Transmitted Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Gastrointestinal Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Gastrointestinal Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Gastrointestinal Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Tropical & Vector-Borne Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Tropical & Vector-Borne Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Tropical & Vector-Borne Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Cardiometabolic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Cardiometabolic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Cardiometabolic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Hematology & Coagulation Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Hematology & Coagulation Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Hematology & Coagulation Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Coagulation Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Coagulation Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Coagulation Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Hematology Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Hematology Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Hematology Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Inflammation & Infection Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Inflammation & Infection Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Inflammation & Infection Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Pregnancy, Fertility & Women’s Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Pregnancy, Fertility & Women’s Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Pregnancy, Fertility & Women’s Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Oncology & Immunology Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Oncology & Immunology Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Oncology & Immunology Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Oncology Biomarkers Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Oncology Biomarkers Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Oncology Biomarkers Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Immunology & Autoimmune Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Immunology & Autoimmune Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Immunology & Autoimmune Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Endocrine & Immune Adjunct Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Endocrine & Immune Adjunct Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Endocrine & Immune Adjunct Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Toxicology & Substance Use Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Toxicology & Substance Use Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Toxicology & Substance Use Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Critical Care & Emergency Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Critical Care & Emergency Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Critical Care & Emergency Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Mobile Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Mobile Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Mobile Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Physician Offices Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Physician Offices Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Physician Offices Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 145. Global Direct Institutional Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Direct Institutional Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Direct Institutional Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Distributors & Wholesalers Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Distributors & Wholesalers Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Distributors & Wholesalers Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global E-commerce & Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global E-commerce & Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global E-commerce & Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Government / Public Sector Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Government / Public Sector Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Government / Public Sector Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 175. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 177. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 178. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 179. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 180. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 182. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 183. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 185. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 186. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 187. North America Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. North America Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 189. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 191. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 192. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 193. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 194. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 195. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 196. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 197. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 199. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 200. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 201. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Europe Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 203. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 204. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 205. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 206. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 207. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 208. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 209. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 210. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 211. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 213. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 214. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 215. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Latin America Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 217. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 218. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 219. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 220. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 221. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 222. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 223. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 224. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 225. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 227. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 228. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 229. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Africa Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 231. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 232. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 233. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 234. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 235. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 236. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 238. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 239. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 241. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 242. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 243. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. Middle East Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 245. Global Point-Of-Care Or Rapid Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 246. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 248. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 249. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 250. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 251. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 252. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 253. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 254. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 256. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 257. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 258. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. NATO Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 260. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 262. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 263. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 264. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 265. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 267. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 268. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 270. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 271. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 272. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. G7 Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 274. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 275. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 276. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 277. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 278. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 279. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 280. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 281. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 282. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 284. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 285. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 286. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. BRICS Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 288. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 289. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 290. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 291. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 292. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 293. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 294. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 295. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 296. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 298. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 299. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 300. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. European Union Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 302. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 303. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 304. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 305. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 306. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 307. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 308. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 309. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 310. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 311. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 312. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testing, 2017-2032 (USD Million)
TABLE 313. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Oncology & Immunology Testing, 2017-2032 (USD Million)
TABLE 314. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. ASEAN Point-Of-Care Or Rapid Diagnostics Market Size, by Distribution Channels, 2017-2032 (USD Million)
TABLE 316. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 317. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Product Offering, 2017-2032 (USD Million)
TABLE 318. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 319. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 320. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 321. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 322. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 323. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Mode of Purchase, 2017-2032 (USD Million)
TABLE 324. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Application, 2017-2032 (USD Million)
TABLE 325. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Infectious Disease Testing, 2017-2032 (USD Million)
TABLE 326. GCC Point-Of-Care Or Rapid Diagnostics Market Size, by Hematology & Coagulation Testi

Companies Mentioned

  • Danaher Corporation
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • QuidelOrtho Corporation
  • Werfen, S.A.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers AG
  • Biosynex SA
  • Cardinal Health, Inc.
  • Nova Biomedical Corporation
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Abaxis, Inc.
  • Abionic SA
  • Biosurfit SA
  • Chembio Diagnostic Systems, Inc.
  • EKF Diagnostics Holdings plc
  • Helena Laboratories Corporation
  • Horiba Group
  • Microlife Corporation
  • Monlab SA
  • Quest Diagnostics Incorporated
  • Sekisui Diagnostics LLC
  • Sysmex Corporation
  • Trinity Biotech plc

Related Topics

Related Reports

Point of Care Testing Market - Global Forecast 2026-2032 - Product Image

Point of Care Testing Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Point of Care Blood Testing Product Market - Global Forecast 2026-2032 - Product Image

Point of Care Blood Testing Product Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Point-of-Care/Rapid Diagnostics - Global Strategic Business Report - Product Image

Point-of-Care/Rapid Diagnostics - Global Strategic Business Report

  • Report
  • 448 Pages
  • Global
From
Point-of-Care Infectious Disease Diagnostics - Global Strategic Business Report - Product Image

Point-of-Care Infectious Disease Diagnostics - Global Strategic Business Report

  • Report
  • 287 Pages
  • Global
From
Point of Care Diagnostics Market by Product, Purchase Mode, Technology, Sample, End User - Global Forecast to 2031 - Product Image

Point of Care Diagnostics Market by Product, Purchase Mode, Technology, Sample, End User - Global Forecast to 2031

  • Report
  • 548 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.